Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis

PLoS Genet. 2016 Mar 15;12(3):e1005931. doi: 10.1371/journal.pgen.1005931. eCollection 2016 Mar.

Abstract

Cancer cells often rely on glycolysis to obtain energy and support anabolic growth. Several studies showed that glycolytic cells are susceptible to cell death when subjected to low glucose availability or to lack of glucose. However, some cancer cells, including glycolytic ones, can efficiently acquire higher tolerance to glucose depletion, leading to their survival and aggressiveness. Although increased resistance to glucose starvation has been shown to be a consequence of signaling pathways and compensatory metabolic routes activation, the full repertoire of the underlying molecular alterations remain elusive. Using omics and computational analyses, we found that cyclic adenosine monophosphate-Protein Kinase A (cAMP-PKA) axis activation is fundamental for cancer cell resistance to glucose starvation and anoikis. Notably, here we show that such a PKA-dependent survival is mediated by parallel activation of autophagy and glutamine utilization that in concert concur to attenuate the endoplasmic reticulum (ER) stress and to sustain cell anabolism. Indeed, the inhibition of PKA-mediated autophagy or glutamine metabolism increased the level of cell death, suggesting that the induction of autophagy and metabolic rewiring by PKA is important for cancer cellular survival under glucose starvation. Importantly, both processes actively participate to cancer cell survival mediated by suspension-activated PKA as well. In addition we identify also a PKA/Src mechanism capable to protect cancer cells from anoikis. Our results reveal for the first time the role of the versatile PKA in cancer cells survival under chronic glucose starvation and anoikis and may be a novel potential target for cancer treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anoikis / genetics
  • Autophagy / genetics*
  • Cell Line, Tumor
  • Cell Survival / genetics
  • Cyclic AMP / genetics*
  • Cyclic AMP / metabolism
  • Cyclic AMP-Dependent Protein Kinases / biosynthesis*
  • Cyclic AMP-Dependent Protein Kinases / genetics
  • Endoplasmic Reticulum Stress
  • Glucose / deficiency
  • Glucose / metabolism
  • Glutamine / metabolism
  • Glycolysis
  • Humans
  • Mice
  • Neoplasms / genetics*
  • Neoplasms / metabolism
  • Starvation
  • Transcriptome

Substances

  • Glutamine
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • Glucose

Grants and funding

FC is supported by grants from Associazione Italiana per la Ricerca sul Cancro (A.I.R.C., IG2014 Id.15364), from the Italian Government (FAR) and partially by SysBioNet (MIUR). RP is supported by fellowship from MIUR and was previously supported by fellowship from SysBioNet. GV is supported by fellowship from Associazione Italiana per la Ricerca sul Cancro (A.I.R.C., IG2014 Id.15364) and was previously supported by fellowship from SysBioNet. SDP is supported by a fellowship from SysBioNet. HDV has been supported by a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (CNPq), Brazil. FR is a PhD student supported by a fellowship from MIUR. CC was the recipient for a MIUR grant (FIRB 2008). YP and RR are partially supported by Cariplo Foundation grant 2013-0955 and Italian Government (FAR). YP has been also supported by a fellowship from MIUR. KH is supported by the Fonds National de la Recherché (FNR), Luxembourg (ATTRACT A10/03). CG is supported by grants from MIUR (grant FIRB RBRN07BMCT) and the Telethon Foundation (projects GGP08017D and GGP110827). LA is supported by SysBioNet (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.